New Insights and Treatments for Schizophrenia Unveiled
Speedy Summary Schizophrenia affects about 23 million people worldwide, with traditional antipsychotic treatments primarily targeting dopamine. A new drug, KarXT, marks a shift by targeting muscarinic receptors, offering potential benefits